Sign in
CompletedNo phase

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

Key facts

Who runs it
Universidad de Burgos
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
32 people enrolled
Started
15 Sept 2025
Ended
30 Apr 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Nutrition education
  • Supplement
  • Placebo
Record updated
30 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Diagnosis: Medical confirmation of Down syndrome (trisomy of chromosome 21)
  • Physical capacity: Ability to perform basic physical tests (e.g., standing up from a chair or walking without assistance)
  • Informed consent: Informed consent will be obtained from both the participant and their legal representative, in compliance with current legislation for individuals requiring support measures

Who cannot take part

  • Chronic kidney disease: Diagnosis of chronic kidney disease
  • Allergies or intolerances: Known allergy to creatine or to components of the placebo (inulin)
  • Severe motor limitations: Inability to perform the required physical tests (e.g., paralysis or mobility impairments preventing the execution of muscle strength assessments)
  • Participation in other studies: Participation in another nutritional or supplementation intervention study within the last 6 months

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Purpose:

Read full original descriptionShow less

This study will test whether 8 weeks of creatine and HMB supplementation can improve muscle strength, body composition, balance, and overall health in people with Down syndrome. Participants will also receive nutrition tips during the study.

Who can participate:

People with Down syndrome who can perform basic physical tasks. Must provide consent from the participant and legal guardian.

What participants will do:

Take creatine (3 g/day) and HMB (3 g/day) or placebo for 8 weeks. Complete tests for muscle strength, balance, and cognitive function. Undergo body composition scans and give blood samples for health markers.

Timing:

All tests and blood samples are taken before and after each 8-week period.

Importance:

Results will help determine if creatine and HMB can safely improve strength, balance, and overall health in people with Down syndrome.

The 2 groups in the trial

  • PlaceboExisting treatment, for comparison

    Participants will receive placebo supplementation

    Treatment: Nutrition education and Placebo

  • SupplementationTreatment being tested

    Participants will receive creatine monohydrate and beta-hydroxy-beta-methylbutyrate supplementation

    Treatment: Nutrition education and Supplement

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 October 2026